Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vikram Thermo (India)BOM:530477 +0.08%80 Current Ratio is 3.30 as of Mar. 2026, which is 34% above its 10-year median of 2.47. GuruFocus rates BOM:530477 with a GF Score™ of 80/100 and a GF Value™ of ₹182.67 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,000 Drug Manufacturers companies, Vikram Thermo (India) ranks better than 70.4% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Vikram Thermo (India)'s current ratio for the quarter that ended in Mar. 2026 was 3.30.
Vikram Thermo (India) has a current ratio of 3.30. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Vikram Thermo (India)'s Current Ratio or its related term are showing as below:
BOM:530477'
s Current Ratio Range Over the Past 10 Years
Min: 1.8 Med: 2.47 Max: 3.57
Current: 3.3
During the past 13 years, Vikram Thermo (India)'s highest Current Ratio was 3.57. The lowest was 1.80. And the median was 2.47.
BOM:530477's Current Ratio is ranked better than 70.4% of 1000
companies
in the Drug Manufacturers industry
Industry Median: 2
vs BOM:530477: 3.30
Vikram Thermo (India) (BOM:530477) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Vikram Thermo (India) Current Ratio Related Terms
Vikram Thermo (India) Current Ratio Historical Data
* Premium members only.
The historical data trend for Vikram Thermo (India)'s Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vikram Thermo (India)'s Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vikram Thermo (India) Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vikram Thermo (India)'s Current Ratio distribution charts can be found below:
* The bar in red indicates where Vikram Thermo (India)'s Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vikram Thermo (India) (BOM:530477) has a Current Ratio of 3.30 as of Mar. 2026. This is 34% above median its historical median of 2.47. Over the past decade, Vikram Thermo (India)'s Current Ratio has ranged from 1.80 to 3.57. According to the industry distribution chart, Vikram Thermo (India) ranks #296 out of 1000 companies in the Drug Manufacturers industry, placing it in the top 29.6%.
Is Vikram Thermo (India)'s Current Ratio too high?
Vikram Thermo (India)'s current Current Ratio of 3.30 is 34% above median its 10-year median of 2.47. Over the past 10 years, this metric has ranged from a low of 1.80 to a high of 3.57. The Drug Manufacturers industry median Current Ratio is 2.00. Vikram Thermo (India)'s value of 3.30 is 65% above this industry median. Based on the distribution chart, Vikram Thermo (India) ranks #296 out of 1000 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Vikram Thermo (India) has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vikram Thermo (India)'s Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vikram Thermo (India) ranks #296 out of 1000 companies for Current Ratio. This puts Vikram Thermo (India) in the upper half of its industry. The industry median Current Ratio is 2.00. Vikram Thermo (India)'s value of 3.30 is 65% above this benchmark. Historically, Vikram Thermo (India)'s own Current Ratio has ranged from 1.80 to 3.57 over the past decade. While the company's 10-year median is 2.47 vs. the industry median of 2.00, Vikram Thermo (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 1,000 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vikram Thermo (India)'s current Current Ratio of 3.30 is 65% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vikram Thermo (India)'s current Current Ratio is 3.30, which is 34% above median its own 10-year median of 2.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vikram Thermo (India) stock overvalued right now?
Based on GuruFocus' analysis, Vikram Thermo (India) (BOM:530477) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹182.67, compared to a current price of ₹245.20 — trading 34.2% above its estimated fair value. The current Current Ratio is 3.30, which is 34% above median its 10-year median of 2.47 and 65% above the Drug Manufacturers industry median of 2.00. Vikram Thermo (India)'s overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Vikram Thermo (India) (BOM:530477), the current Current Ratio is 3.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vikram Thermo (India) (BOM:530477) Overvalued in 2026?
Based on GuruFocus' analysis, Vikram Thermo (India) stock appears to be overvalued.
The current stock price of ₹245.20 is trading 34.2% above its estimated GF Value™ of ₹182.67.
GuruFocus considers Vikram Thermo (India) to be Significantly Overvalued.
Key valuation signals for BOM:530477:
Current Ratio: 3.30 (34% above median its 10-year median of 2.47)
GF Value™: ₹182.67 vs. price of ₹245.20 (34.2% above fair value)
Industry Position: 65% above the Drug Manufacturers median (#296 of 1000)
No single metric tells the full story. See the BOM:530477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vikram Thermo (India) Ltd is engaged in the manufacturing and selling of basic pharma co-polymer Drug Coat, Diphenyl Oxide, Aquapol line of cosmetic polymers, and Apion line of cross-linked polymers. Through its products, the company provides a complete solution for various applications in the solid oral dosage coating segment with complementary technical support. It operates in a single segment, Chemicals. Geographically, the company generates maximum revenue from its business in India, followed by the Rest of the world.
80GF Score
Get the complete analysis for BOM:530477
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530477 has been successfully added to your 
